Non-Alcoholic Fatty Liver Disease Proven by Transient Elastography in Hemodialysis Patients: Is It a New Risk Factor for Adverse Cardiovascular Events?

Background/Aims: Cardiovascular diseases (CVD) are the leading cause of mortality in hemodialysis (HD) patients. Recently, non-alcoholic fatty liver disease (NAFLD) has been recognized as a new risk factor for adverse CVD events in the general population. Our aim was to analyze the incidence of NAFLD in HD patients by using transient elastography and to analyze whether the presence of NAFLD is associated with a higher CVD risk in HD patients. Methods: The subjects were 72 HD patients and 50 sex- and age-matched controls. Results: NAFLD was found in 52.8% of HD patients. HD patients with NAFLD showed more carotid atherosclerosis and more adverse CVD events than HD patients without NAFLD and control subjects. Conclusion: We showed for the first time that HD patients have a high prevalence of NAFLD. HD patients with NAFLD show an advanced carotid atherosclerosis. Detection of NAFLD by transient elastography should alert to the existence of an increased cardiovascular risk in HD patients.

[1]  L. Orlić,et al.  Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients. , 2014, Medical hypotheses.

[2]  D. S̆timac,et al.  Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease Proven by Transient Elastography , 2013, Kidney and Blood Pressure Research.

[3]  E. Lopes,et al.  Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysis , 2012 .

[4]  L. Sandrin,et al.  The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. , 2012, Clinics and research in hepatology and gastroenterology.

[5]  A. Martín-Malo,et al.  Risk Factors Associated with Cardiovascular Morbidity and Mortality in Spanish Incident Hemodialysis Patients: Two-Year Results from the ANSWER Study , 2011, Blood Purification.

[6]  P. Newsome,et al.  Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis , 2010, Alimentary pharmacology & therapeutics.

[7]  Giuseppe Lippi,et al.  Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[8]  V. de Lédinghen,et al.  Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. , 2010, Ultrasound in medicine & biology.

[9]  Enzo Bonora,et al.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[10]  A. Sanyal,et al.  Recent advances in nonalcoholic fatty liver disease , 2010, Current opinion in gastroenterology.

[11]  R. Farah,et al.  Presence of coronary plaques in patients with nonalcoholic fatty liver disease. , 2010, Radiology.

[12]  A. Sanyal,et al.  Recent advances in nonalcoholic fatty liver disease , 2009, Current opinion in gastroenterology.

[13]  G. Targher,et al.  Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. , 2007, Atherosclerosis.

[14]  G. Farrell,et al.  Nonalcoholic fatty liver disease: From steatosis to cirrhosis , 2006, Hepatology.

[15]  G. Marchesini,et al.  Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease , 2005, Hepatology.

[16]  Z. Massy,et al.  Chronic kidney disease as cause of cardiovascular morbidity and mortality. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  Emilio Ros,et al.  Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case–Control Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[18]  F. Locatelli,et al.  Epidemiology of cardiovascular risk in patients with chronic kidney disease. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  Jeff Davies.  Reproduced with the permission of Bird life Australia and , 2013 .